Altmann, Patrick
De Simoni, Desiree
Kaider, Alexandra
Ludwig, Birgit
Rath, Jakob
Leutmezer, Fritz
Zimprich, Fritz
Hoeftberger, Romana
Lunn, Michael P.
Heslegrave, Amanda
Berger, Thomas
Zetterberg, Henrik
Rommer, Paulus Stefan https://orcid.org/0000-0001-5209-6647
Article History
Received: 20 October 2019
Accepted: 5 February 2020
First Online: 17 March 2020
Ethics approval and consent to participate
: This study was approved by the ethics committee at the Medical University of Vienna (#1283/2018) and written informed consent for biobanking was obtained.
: Not applicable.
: MPL is a member of the scientific advisory boards for CSL Behring, Novartis and UCB Pharma and has minor unconditional travel grants to relevant meetings from CSL Behring (all outside the submitted work). HZ is a member of the scientific advisory boards for Roche Diagnostics, Wave, Samumed and CogRx; lectures in symposia sponsored by Biogen and Alzecure; and is co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg (all outside the submitted work). The other authors declare that they have no competing interests.